The US Drug Enforcement Agency (DEA) have agreed on recommending the reclassifying of cannabis to a schedule III drug, today its classified as a schedule I with no medical benefits. This is historical and cannabis stocks saw a boost in value after the news become public.
https://norml.org/blog/2024/04/30/dea-accepts-health-agencys-recommendation-to-reclassify-cannabis/

norml.org

DEA Accepts Health Agency’s Recommendation to Reclassify Cannabis

Determination must be reviewed by the White House Office of Management and Budget